De-Escalation Therapy for Human Papillomavirus Negative Disease
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
This study is looking to see if nivolumab, an immunotherapy drug, given with carboplatin and
paclitaxel (2 chemotherapy agents) during induction therapy in advanced stage HPV negative
patients can significantly shrink the subject's cancer.